Metal nanoparticles have demonstrated broad and promising biomedical applications in research laboratories, but to fulfill their potential in the clinic demands extensive effort to minimize their non‐specific accumulation in the body.

Metal nanoparticles have demonstrated broad and promising biomedical applications in research laboratories, but to fulfill their potential in the clinic demands extensive effort to minimize their non‐specific accumulation in the body.
In an effort to overcome barriers to the treatment of glioblastoma (GBM), targeted nanotherapeutics have emerged as promising drug delivery systems with the potential to improve pharmacokinetic profiles and therapeutic efficacy.
Nano- and micro-particulate vaccine delivery systems minimize side effects, trigger targeted and robust immune responses, and protect and stabilize vaccine components
Researchers are applying nanotechnology to cancer immunotherapy toward the development of nanocarriers for delivery of cancer vaccines and chemo-immunotherapies.
Single-cell RNA analysis is now possible through innovative platforms combining state-of-the-art microscopy methods with various contrast-generating nanomaterials